SCHEMBL2645435

SCHEMBL2645435

O=C(O)/C(=C/C1CCCCC1)c1ccc(F)c(F)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 1/20 0.44
TAS1R1 Q7RTX1 1/20 0.44
TAS1R2 Q8TE23 1/20 0.44
CES2 O00748 2/20 0.43
CES1 P23141 2/20 0.43
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HSD11B1 P28845 1/20 0.37
SSTR3 P32745 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
CHRM5 P08912 1/20 0.35
SRD5A2 P31213 1/20 0.35
PLA2G7 Q13093 1/20 0.35
KCNQ3 O43525 1/20 0.34
KCNQ2 O43526 1/20 0.34
PGR P06401 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2645437 1.00 TAS1R3 (0.44) TAS1R3TAS1R1TAS1R2CES2CES1
SCHEMBL2646968 0.83 TAS1R3 (0.46) TAS1R3TAS1R1TAS1R2CES2CES1
SCHEMBL2646970 0.83 TAS1R3 (0.46) TAS1R3TAS1R1TAS1R2CES2CES1
SCHEMBL13609535 0.80 COMT (0.35) TAS1R3TAS1R1TAS1R2SRD5A2ALDH1A1
SCHEMBL10592287 0.78 AKR1C1 (0.47) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL10592284 0.78 AKR1C1 (0.47) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL2646441 0.78 TSHR (0.47) TAS1R3TAS1R2KMT2ASRD5A2ALDH1A1
SCHEMBL2646437 0.78 TSHR (0.47) TAS1R3TAS1R2KMT2ASRD5A2ALDH1A1
SCHEMBL2650716 0.78 RARA (0.34) TAS1R3TAS1R1TAS1R2
SCHEMBL2645851 0.77 TAS1R3 (0.42) TAS1R3TAS1R1TAS1R2CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242397-B1 TRANS OLEFINIC GLUCOKINASE ACTIVATORS HOFFMANN LA ROCHE (CH) 2005-09-28 EP disclosed
EP-1242397-A1 TRANS OLEFINIC GLUCOKINASE ACTIVATORS F. HOFFMANN-LA ROCHE AG (CH) 2002-09-25 EP disclosed
US-6353111-B1 WHICH INCREASE INSULIN SECRETION IN THE TREATMENT OF TYPE II DIABETES; 2,3-DI-SUBSTITUTED TRANS OLEFINIC N-HETEROAROMATIC OR URIDO PROPIONAMIDES: THE SUBSTITUTION AT THE 2-POSITION BEING A SUBSTITUTED PHENYL GROUP AND AT THE 3-POSITION A HOFFMANN-LA ROCHE INC. 2002-03-05 US disclosed
WO-2001044216-A1 TRANS OLEFINIC GLUCOKINASE ACTIVATORS F. HOFFMANN-LA ROCHE AG (CH) 2001-06-21 WO disclosed